Durgical
EN
Open the app

Peripheral ulcerative keratitis and Mooren ulcer

A painful crescent ulcer that thins the edge of the cornea. It often signals active systemic vasculitis, such as rheumatoid arthritis.

Updated

What it is

Crescent-shaped inflammatory destruction of the peripheral corneal stroma next to the limbus, with an epithelial defect. About half of cases accompany systemic autoimmune disease, mostly rheumatoid arthritis and ANCA vasculitis, and may herald fatal vasculitis. Mooren ulcer is the idiopathic, very painful form.

See it in 3D

Who gets it

Rare, with an estimated incidence of about 3 per million per year. Rheumatoid arthritis is the most common systemic association. Mooren ulcer is more common in men, and bilateral aggressive forms are reported in young men from Africa, Asia and other tropical regions.

Causes

Risk factors

  • Long-standing, poorly controlled rheumatoid arthritis
  • Active systemic vasculitis
  • Ocular surgery or trauma (Mooren ulcer)
  • Hepatitis C and helminth infections (Mooren ulcer in some regions)

Pathophysiology

The peripheral cornea receives immune complexes and inflammatory cells from limbal vessels. Immune complex deposition activates complement and recruits neutrophils, which release collagenases and matrix metalloproteinases that digest the stroma. Ongoing vasculitis keeps the process active until the cornea melts or perforates.

Classification

  • Associated with systemic autoimmune disease or vasculitis
  • Infectious
  • Mooren ulcer (diagnosis of exclusion): limited unilateral, or bilateral aggressive

Symptoms and signs

  • Pain, often severe (especially Mooren ulcer)
  • Redness, watering and light sensitivity
  • Crescent ulcer at the corneal edge with stromal thinning
  • Overhanging edge on the central side in Mooren ulcer
  • Adjacent scleritis in some patients

Diagnosis

Clinical
Slit-lamp examination with fluorescein shows an epithelial defect with peripheral stromal thinning; examine the sclera; full systemic history and examination.
Tests
Full blood count, kidney function and urinalysis, inflammatory markers, rheumatoid factor and anti-CCP, ANCA, ANA, hepatitis B and C serology, syphilis serology; corneal scraping and culture to exclude infection.
Imaging
Anterior segment optical coherence tomography to measure thinning; chest radiograph or CT and sinus imaging when vasculitis is suspected.

Differential diagnosis

Peripheral corneal thinning or infiltrate: which one is it?

FeaturePUK and Mooren ulcerMarginal keratitisTerrien marginal degeneration
PainSevereMild to moderateNone
EpitheliumDefect over the thinningIntact or a minimal defectIntact
InflammationMarked redness, sometimes adjacent scleritisModerate redness near the infiltrateQuiet eye; yellow lipid line at the leading edge
ThinningProgressive, can perforateLittle or noneSlow over years, usually superior
CauseSystemic vasculitis, infection, or idiopathic (Mooren)Staphylococcal antigens from blepharitisIdiopathic degeneration

Goal of treatment

Stop the melting, prevent perforation and control the underlying systemic disease urgently with rheumatology.

Treatment

Acute
Same-day referral; lubricants, protection and topical antibiotic prophylaxis for the epithelial defect; oral tetracycline-class drug to inhibit collagenase.
Medical
Systemic corticosteroids plus steroid-sparing immunosuppression (methotrexate, mycophenolate, cyclophosphamide or rituximab) for vasculitis-associated PUK and Mooren ulcer.
Surgical
Conjunctival resection next to the ulcer, amniotic membrane, tissue adhesive, or a lamellar or patch graft for severe thinning or perforation.

Complications

Common traps

  • PUK is an eye disease that drops alone can control: the melt is driven by systemic immune disease, so it needs systemic immunosuppression with rheumatology; topical treatment only protects the surface
  • Quiet joints mean no systemic cause: PUK can be the first sign of granulomatosis with polyangiitis or another vasculitis, so ANCA, kidney function, urinalysis and chest imaging are checked in every patient
  • Any painful peripheral ulcer is a Mooren ulcer: Mooren ulcer is a diagnosis of exclusion, made only after systemic and infectious causes have been ruled out
  • All peripheral thinning is PUK: painless thinning with intact epithelium and a lipid line is Terrien degeneration; PUK is painful, inflamed and has an epithelial defect
  • PUK only threatens the eye: untreated vasculitis-associated PUK carries a high mortality, so the systemic work-up is as urgent as protecting the cornea

Prognosis

Vision is often preserved with prompt systemic immunosuppression. Untreated PUK with vasculitis carries a high mortality. Bilateral aggressive Mooren ulcer is the hardest to control.

Test yourself

Think of the answer, then tap the question to see it.

A woman with long-standing rheumatoid arthritis has a painful red eye with a crescent ulcer and thinning at the corneal edge. What is the priority?

Same-day ophthalmology and urgent systemic work-up: PUK signals active vasculitis, and systemic immunosuppression with rheumatology is needed to stop the melt.

Why does PUK affect the edge rather than the centre of the cornea?

The periphery lies next to the limbal vessels, which deliver immune complexes, complement and neutrophils; their collagenases digest the nearby stroma.

A patient with PUK also has haematuria and chronic sinusitis. Which disease is likely, and which test?

Granulomatosis with polyangiitis; ANCA testing, with kidney function, urinalysis and chest imaging.

Why is an oral tetracycline-class drug added in PUK?

It inhibits collagenase and matrix metalloproteinases, slowing the stromal melt while systemic immunosuppression takes effect.

When can a diagnosis of Mooren ulcer be made?

Only after systemic autoimmune, vasculitic and infectious causes have been excluded, in a painful peripheral ulcer with an undermined central edge.

Add to my cards (5)

Connections

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Peripheral Ulcerative Keratitis (StatPearls Publishing (NCBI Bookshelf), 2024); Mooren's Ulcer (EyeWiki, American Academy of Ophthalmology, 2026).

← All conditions

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.